{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T22:09:01Z","timestamp":1775340541051,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Quality of life following extracorporeal membrane oxygenation (ECMO) therapy is an important health issue. We aimed to describe the characteristics of patients who developed chronic respiratory disease (CRD) following ECMO therapy, and investigate the association between newly diagnosed post-ECMO CRDs and 5-year all-cause mortality among ECMO survivors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed data from the National Health Insurance Service in South Korea. All adult patients who underwent ECMO therapy in the intensive care unit between 2006 and 2014 were included. ECMO survivors were defined as those who survived for 365\u00a0days after ECMO therapy. Chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, lung cancer, lung disease due to external agents, obstructive sleep apnea, and lung tuberculosis were considered as CRDs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 3055 ECMO survivors were included, and 345 (11.3%) were newly diagnosed with CRDs 365\u00a0days after ECMO therapy. The prevalence of asthma was the highest at 6.1% (185). In the multivariate logistic regression, ECMO survivors who underwent ECMO therapy for acute respiratory distress syndrome (ARDS) or respiratory failure had a 2.00-fold increase in post-ECMO CRD (95% confidence interval [CI]: 1.39 to 2.89; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). In the multivariate Cox regression, newly diagnosed post-ECMO CRD was associated with a 1.47-fold (95% CI: 1.17 to 1.86; <jats:italic>P<\/jats:italic>\u2009=\u20090.001) higher 5-year all-cause mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>At 12\u00a0months after ECMO therapy, 11.3% of ECMO survivors were newly diagnosed with CRDs. Patients who underwent ECMO therapy for ARDS or respiratory failure were associated with a higher incidence of newly diagnosed post-ECMO CRD compared to those who underwent ECMO for other causes. Additionally, post-ECMO CRDs were associated with a higher 5-year all-cause mortality. Our results suggest that ECMO survivors with newly diagnosed post-ECMO CRD might be a high-risk group requiring dedicated interventions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-021-01796-8","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T08:10:58Z","timestamp":1625472658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chronic respiratory disease and survival outcomes after extracorporeal membrane oxygenation"],"prefix":"10.1186","volume":"22","author":[{"given":"Tak Kyu","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoung-Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hun-Taek","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-4253","authenticated-orcid":false,"given":"In-Ae","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"key":"1796_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/cc10490","volume":"15","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni L, Carlesso E, Langer T. Clinical review: extracorporeal membrane oxygenation. Crit Care. 2011;15:243.","journal-title":"Crit Care"},{"key":"1796_CR2","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","volume":"378","author":"A Combes","year":"2018","unstructured":"Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C, Da Silva D, Zafrani L, Tirot P, Veber B, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965\u201375.","journal-title":"N Engl J Med"},{"key":"1796_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.hlc.2013.08.009","volume":"23","author":"G Lafc","year":"2014","unstructured":"Lafc G, Budak AB, Yener AU, Cicek OF. Use of extracorporeal membrane oxygenation in adults. Heart Lung Circ. 2014;23:10\u201323.","journal-title":"Heart Lung Circ"},{"key":"1796_CR4","volume":"1","author":"R Tramm","year":"2015","unstructured":"Tramm R, Ilic D, Davies AR, Pellegrino VA, Romero L, Hodgson C. Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database Syst Rev. 2015;1: CD010381.","journal-title":"Cochrane Database Syst Rev"},{"key":"1796_CR5","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1161\/CIRCULATIONAHA.119.034512","volume":"140","author":"PM Eckman","year":"2019","unstructured":"Eckman PM, Katz JN, El Banayosy A, Bohula EA, Sun B, van Diepen S. Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock: an introduction for the busy clinician. Circulation. 2019;140:2019\u201337.","journal-title":"Circulation"},{"key":"1796_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jama.2019.9302","volume":"322","author":"D Brodie","year":"2019","unstructured":"Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications: a review. JAMA. 2019;322:557\u201368.","journal-title":"JAMA"},{"key":"1796_CR7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00134-018-5182-0","volume":"44","author":"A Aneman","year":"2018","unstructured":"Aneman A, Brechot N, Brodie D, Colreavy F, Fraser J, Gomersall C, McCanny P, Moller-Sorensen PH, Takala J, Valchanov K, Vallely M. Advances in critical care management of patients undergoing cardiac surgery. Intensive Care Med. 2018;44:799\u2013810.","journal-title":"Intensive Care Med"},{"key":"1796_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.semtcvs.2015.07.005","volume":"27","author":"FH McCarthy","year":"2015","unstructured":"McCarthy FH, McDermott KM, Kini V, Gutsche JT, Wald JW, Xie D, Szeto WY, Bermudez CA, Atluri P, Acker MA, Desai ND. Trends in US extracorporeal membrane oxygenation use and outcomes: 2002\u20132012. Semin Thorac Cardiovasc Surg. 2015;27:81\u20138.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"1796_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.005929","volume":"12","author":"S Vallabhajosyula","year":"2019","unstructured":"Vallabhajosyula S, Prasad A, Bell MR, Sandhu GS, Eleid MF, Dunlay SM, Schears GJ, Stulak JM, Singh M, Gersh BJ, et al. Extracorporeal membrane oxygenation use in acute myocardial infarction in the United States, 2000 to 2014. Circ Heart Fail. 2019;12: e005929.","journal-title":"Circ Heart Fail"},{"key":"1796_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcrc.2018.09.035","volume":"49","author":"CK Tay","year":"2019","unstructured":"Tay CK, Cho YH, Park J, Yang JH, Chung CR, Sung K, Cho J, Kang D, Park H, Suh GY. Extracorporeal membrane oxygenation in Korea\u2014trends and impact of hospital volume on outcome: analysis of national insurance data 2009\u20132014. J Crit Care. 2019;49:1\u20136.","journal-title":"J Crit Care"},{"key":"1796_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00134-016-4273-z","volume":"42","author":"C Karagiannidis","year":"2016","unstructured":"Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T, Muller T, Windisch W. Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med. 2016;42:889\u201396.","journal-title":"Intensive Care Med"},{"key":"1796_CR12","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/CCM.0000000000004447","volume":"48","author":"X Yang","year":"2020","unstructured":"Yang X, Cai S, Luo Y, Zhu F, Hu M, Zhao Y, Zheng R, Li X, Hu B, Peng Z. Extracorporeal membrane oxygenation for coronavirus disease 2019\u2014induced acute respiratory distress syndrome: a multicenter descriptive study. Crit Care Med. 2020;48:1289\u201395.","journal-title":"Crit Care Med"},{"key":"1796_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0140-6736(20)32008-0","volume":"396","author":"RP Barbaro","year":"2020","unstructured":"Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, Bartlett RH, Tonna JE, Hyslop R, Fanning JJ, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396:1071\u20138.","journal-title":"Lancet"},{"key":"1796_CR14","first-page":"172","volume":"15","author":"A Zangrillo","year":"2013","unstructured":"Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, Patroniti N, Antonelli M, Pesenti A, Pappalardo F. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013;15:172\u20138.","journal-title":"Crit Care Resusc"},{"key":"1796_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-2293-5","volume":"23","author":"MS Baek","year":"2019","unstructured":"Baek MS, Lee SM, Chung CR, Cho WH, Cho YJ, Park S, Koo SM, Jung JS, Park SY, Chang Y, et al. Improvement in the survival rates of extracorporeal membrane oxygenation-supported respiratory failure patients: a multicenter retrospective study in Korean patients. Crit Care. 2019;23:1.","journal-title":"Crit Care"},{"key":"1796_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/ALN.0000000000002624","volume":"130","author":"G Grasselli","year":"2019","unstructured":"Grasselli G, Scaravilli V, Tubiolo D, Russo R, Crimella F, Bichi F, Morlacchi LC, Scotti E, Patrini L, Gattinoni L, et al. Quality of life and lung function in survivors of extracorporeal membrane oxygenation for acute respiratory distress syndrome. Anesthesiology. 2019;130:572\u201380.","journal-title":"Anesthesiology"},{"key":"1796_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1399-6576.2008.01808.x","volume":"53","author":"VB Linden","year":"2009","unstructured":"Linden VB, Lidegran MK, Frisen G, Dahlgren P, Frenckner BP, Larsen F. ECMO in ARDS: a long-term follow-up study regarding pulmonary morphology and function and health-related quality of life. Acta Anaesthesiol Scand. 2009;53:489\u201395.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1796_CR18","doi-asserted-by":"publisher","first-page":"102829","DOI":"10.1016\/j.iccn.2020.102829","volume":"59","author":"JM Tiedebohl","year":"2020","unstructured":"Tiedebohl JM, DeFabio ME, Bell T, Buchko BL, Woods AB. ECMO survivors\u2019 quality of life and needs after discharge: a descriptive, comparative cross-sectional pilot study. Intensive Crit Care Nurs. 2020;59:102829.","journal-title":"Intensive Crit Care Nurs"},{"key":"1796_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0267659119830244","volume":"34","author":"V von Bahr","year":"2019","unstructured":"von Bahr V, Kalzen H, Frenckner B, Hultman J, Frisen KG, Lidegran MK, Diaz S, Malfertheiner MV, Millar JE, Dobrosavljevic T, et al. Long-term pulmonary function and quality of life in adults after extracorporeal membrane oxygenation for respiratory failure. Perfusion. 2019;34:49\u201357.","journal-title":"Perfusion"},{"key":"1796_CR20","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288\u201394.","journal-title":"J Clin Epidemiol"},{"key":"1796_CR21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1164\/rccm.201409-1634OC","volume":"191","author":"RP Barbaro","year":"2015","unstructured":"Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM, Annich GM. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med. 2015;191:894\u2013901.","journal-title":"Am J Respir Crit Care Med"},{"key":"1796_CR22","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2021.01.027","author":"F Biancari","year":"2021","unstructured":"Biancari F, Mariscalco G, Dalen M, Settembre N, Welp H, Perrotti A, Wiebe K, Leo E, Loforte A, Chocron S, et al. Six-month survival after extracorporeal membrane oxygenation for severe COVID-19. J Cardiothorac Vasc Anesth. 2021. https:\/\/doi.org\/10.1053\/j.jvca.2021.01.027.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"1796_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13054-020-02937-z","volume":"24","author":"A Roumy","year":"2020","unstructured":"Roumy A, Liaudet L, Rusca M, Marcucci C, Kirsch M. Pulmonary complications associated with veno-arterial extra-corporeal membrane oxygenation: a comprehensive review. Crit Care. 2020;24:212.","journal-title":"Crit Care"},{"key":"1796_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2011-0392TR","volume":"46","author":"M Bhatia","year":"2012","unstructured":"Bhatia M, Zemans RL, Jeyaseelan S. Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol. 2012;46:566\u201372.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1796_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12967-015-0634-6","volume":"13","author":"P Ostadal","year":"2015","unstructured":"Ostadal P, Mlcek M, Kruger A, Hala P, Lacko S, Mates M, Vondrakova D, Svoboda T, Hrachovina M, Janotka M, et al. Increasing venoarterial extracorporeal membrane oxygenation flow negatively affects left ventricular performance in a porcine model of cardiogenic shock. J Transl Med. 2015;13:266.","journal-title":"J Transl Med"},{"key":"1796_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1165\/rcmb.2012-0137TR","volume":"48","author":"S Frohlich","year":"2013","unstructured":"Frohlich S, Boylan J, McLoughlin P. Hypoxia-induced inflammation in the lung: a potential therapeutic target in acute lung injury? Am J Respir Cell Mol Biol. 2013;48:271\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1796_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1010-7940(01)00581-4","volume":"19","author":"C Schlensak","year":"2001","unstructured":"Schlensak C, Doenst T, Preusser S, Wunderlich M, Kleinschmidt M, Beyersdorf F. Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischemia of the lung in piglets: assessment of bronchial artery blood flow with fluorescent microspheres. Eur J Cardiothorac Surg. 2001;19:326\u201331; disciussion 331-322.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1796_CR28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/00003246-199504000-00022","volume":"23","author":"A Vardi","year":"1995","unstructured":"Vardi A, Jessen ME, Chao RY, Brink LW, Levin DL, Johnson RL. Effect of extracorporeal membrane oxygenation flow on pulmonary capillary blood flow. Crit Care Med. 1995;23:726\u201332.","journal-title":"Crit Care Med"},{"key":"1796_CR29","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/MAT.0b013e3182a9e341","volume":"59","author":"AA Rosenberg","year":"2013","unstructured":"Rosenberg AA, Haft JW, Bartlett R, Iwashyna TJ, Huang SK, Lynch WR, Napolitano LM. Prolonged duration ECMO for ARDS: futility, native lung recovery, or transplantation? ASAIO J. 2013;59:642\u201350.","journal-title":"ASAIO J"},{"key":"1796_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jcrc.2016.01.001","volume":"32","author":"DL Staudacher","year":"2016","unstructured":"Staudacher DL, Bode C, Wengenmayer T. Duration of extracorporeal membrane oxygenation is a poor predictor of hospital survival. J Crit Care. 2016;32:207\u20138.","journal-title":"J Crit Care"},{"key":"1796_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40560-020-00480-1","volume":"8","author":"HJ Yeo","year":"2020","unstructured":"Yeo HJ, Kim YS, Kim D, Committee ER, Cho WH. Risk factors for complete recovery of adults after weaning from veno-venous extracorporeal membrane oxygenation for severe acute respiratory failure: an analysis from adult patients in the Extracorporeal Life Support Organization registry. J Intensive Care. 2020;8:64.","journal-title":"J Intensive Care"},{"key":"1796_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1513\/pats.200907-073DP","volume":"6","author":"EF Wouters","year":"2009","unstructured":"Wouters EF, Reynaert NL, Dentener MA, Vernooy JH. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc Am Thorac Soc. 2009;6:638\u201347.","journal-title":"Proc Am Thorac Soc"},{"key":"1796_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s13054-016-1570-4","volume":"20","author":"JE Millar","year":"2016","unstructured":"Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016;20:387.","journal-title":"Crit Care"},{"key":"1796_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s13054-020-03270-1","volume":"24","author":"W Cheng","year":"2020","unstructured":"Cheng W, Ma XD, Su LX, He HW, Wang L, Tang B, Du W, Zhou YK, Wang H, Cui N, et al. Cross-sectional study for the clinical application of extracorporeal membrane oxygenation in Mainland China, 2018. Crit Care. 2020;24:554.","journal-title":"Crit Care"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01796-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-021-01796-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01796-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T08:13:05Z","timestamp":1625472785000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-021-01796-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1796"],"URL":"https:\/\/doi.org\/10.1186\/s12931-021-01796-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]},"assertion":[{"value":"14 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As a population-based cohort study, the study protocol was approved by the Institutional Review Board of the Seoul National University Bundang Hospital (approval number: X-2001-586-902) and the Health Insurance Review and Assessment Service. The requirement for informed consent was waived because the data analyses were performed retrospectively using anonymized data derived from the South Korean NHIS database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}